Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIFLUOPERAZINE for Depression: Side Effects & Safety Data

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

There are 6 adverse event reports in the FDA FAERS database where TRIFLUOPERAZINE was used for Depression.

Most Reported Side Effects for TRIFLUOPERAZINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 198 53.7% 0 180
Suicide attempt 161 43.6% 2 155
Weight increased 159 43.1% 0 156
Akathisia 152 41.2% 0 152
Toxicity to various agents 151 40.9% 2 146
Euphoric mood 148 40.1% 0 148
Increased appetite 147 39.8% 0 147
Obsessive-compulsive disorder 147 39.8% 0 146
Antipsychotic drug level below therapeutic 145 39.3% 0 145
Disinhibition 145 39.3% 0 145
Therapeutic product effect variable 139 37.7% 0 139
Therapeutic product effect incomplete 138 37.4% 0 137
Leukopenia 127 34.4% 0 125
Leukaemia 85 23.0% 0 85
Product use in unapproved indication 83 22.5% 0 81

Other Indications for TRIFLUOPERAZINE

Schizophrenia (168) Product used for unknown indication (101) Schizoaffective disorder bipolar type (33) Psychotic disorder (24) Schizoaffective disorder (12) Bipolar disorder (7) Intentional self-injury (7) Mental disorder (5)

Other Drugs Used for Depression

SERTRALINE (14,497) VENLAFAXINE (11,868) DULOXETINE (11,681) ESKETAMINE (10,058) ESCITALOPRAM OXALATE (7,373) FLUOXETINE (7,035) BUPROPION (6,165) MIRTAZAPINE (6,021) CITALOPRAM HYDROBROMIDE (5,450) PAROXETINE (5,386)

Related Pages

TRIFLUOPERAZINE Full Profile All Depression Drugs TRIFLUOPERAZINE Demographics TRIFLUOPERAZINE Timeline